$3.850
-0.022 (-0.57%)收盤時
CYCU 資訊
CYCU 事件
Cycurion Inc Trading Halted, News Pending
Cycurion Inc trading halted, news pending
Cycurion Granted U.S. Patent No. 12,711,989
Cycurion announced that the U.S. Patent and Trademark Office has granted U.S. Patent No. 12,711,989, "Computer Program, Method, and System for Managing Multiple Data Recording Devices," adding to the intellectual property portfolio acquired with the Digital Ally video solutions business. The grant follows the company's recently announced fleet-driver-analytics patent covering the same platform. The newly granted patent extends the company's VuLink auto-activation family - originally covered by U.S. Patent No. 8,781,292 and continuation No. 10,885,937 - with a system for managing data across multiple recording devices.
Cycurion Secures $54.6M Contract Award
Cycurion announced a 10-year contract award secured through a partnership with a global consulting firm. The agreement supports the modernization and secure operation of a major Health and Human Services System for a state government agency. The contract carries a total value of approximately $54.6M, with expected annual revenue exceeding $5M. Work is scheduled to commence in November.
Cycurion Receives Delisting Determination Letter from Nasdaq
Cycurion has received a delisting determination letter from Nasdaq related to its minimum bid price requirement. The closing bid price of the company's common stock was below the $1.00 per share minimum required for continued listing for the 31 consecutive business days from May 26 through July 9. Because the company effected a 1-for-30 reverse stock split on October 27, 2025, Nasdaq further determined that the company is not eligible for the customary 180-calendar day compliance period and absent a timely hearing request, trading in the company's securities is expected to be suspended at the opening of business on July 21. The company plans to timely request a hearing before the Nasdaq Hearings Panel before the July deadline. A timely hearing request will stay the suspension of the company's securities. Cycurion's common stock will remain listed and continue trading on Nasdaq during the appeal process and pending a final determination by the Hearings Panel. The Board continues to evaluate all available options for regaining compliance with Nasdaq's continued listing requirements.
Cycurion CEO States No 7-for-1 Reverse Split
In a letter to shareholders, CEO Kevin Kelly said, in part, "Cycurion's first obligation is to protect and build shareholder value, and to maintain our listing through sustainable, fundamentals-driven performance rather than short-term price optics. After careful deliberation, the Board of Directors and Management have determined that a 7-for-1 reverse stock split is not in the best interest of shareholders at this time. Our focus is on growing the business, and management expects that continued growth will, over time, be reflected in the price of the stock. Management further believes that pursuing a reverse split now would not protect shareholders and would divert the Company from the work that creates value. Based on the Company's prior experience, the trading record we have analyzed, and the evidence we have collected and continue to collect, management concluded that another reverse split carried a substantial risk of harming shareholders while failing to resolve the underlying issues...The Company's conclusion that its stock has been the target of trading activity inconsistent with fair and orderly markets is not speculation. In October 2025, approximately 89.9 million shares of CYCU changed hands in a single session against a float of roughly 86.5 million shares. More than 100% of the float turned over in a single day - an event that, in Management's view, is not consistent with legitimate market activity. The pattern was repeated this spring. On March 16, 2026, CYCU fell approximately 45% intraday - from a prior close near $1.75 to a low of $0.96 - triggering the Regulation SHO Rule 201 short-sale circuit breaker at 9:30:01 a.m. That safeguard is meant to restrain short selling once a stock has dropped 10% or more. Yet on precisely the two days the restriction was in force, the records reflect a pronounced surge in short sales, most marked "short exempt" - a designation that, if misused, permits short selling to continue at or below the prevailing bid during the window when it is supposed to be curtailed...The order records suggest trading behavior consistent with additional acts of manipulation, including 'spoofing' - including an unusually high number of orders placed and executed, followed by rapid sequencing of cancellations, creating a false impression of supply and demand. The Company intends to follow the evidence and, if appropriate, pursue those parties responsible for improper trading and market manipulation identified in our review. In connection with these efforts, the Company is in contact with NASDAQ regarding this trading activity and the actions Cycurion is taking, and we will continue to work with the exchange as our investigation proceeds, recognizing that the timing and outcome of any regulatory or enforcement actions remain inherently uncertain. Again, deciding not to engage in a reverse stock split was a shareholder-protection decision: it preserved shareholder positions and gave the Company the ability to continue pursuing the remedies it believes best protect investors, including holding accountable those responsible for what the Company views as improper trading and market manipulation in its stock. Management recognizes that the last several quarters have not been a smooth road for investors. The volatility in CYCU's share price, particularly when it has not reflected the progress and growth of the business, has been frustrating and, for many long-term shareholders, painful."
本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。



